scholarly journals The Inaugural Australian Centre for Hepatitis Virology Public Panel Discussion on Viral Hepatitis Research—Lessons in Scientific Community Outreach

Viruses ◽  
2021 ◽  
Vol 13 (9) ◽  
pp. 1838
Author(s):  
Thomas Tu ◽  
Chaturaka Rodrigo ◽  
Simone I Strasser ◽  
D Scott Bowden ◽  
Jennifer H MacLachlan ◽  
...  

Viral hepatitis remains one of the most significant health issues globally, directly responsible for over 1 million deaths each year and affecting almost 300 million people around the world. Scientific research in recent decades has brought about improvements in the lives of people living with chronic viral hepatitis. On the 29 July 2021, the Australian Centre for Hepatitis Virology (ACHV) for the first time held a public educational forum for the general public. The main aim of this event was to inform the affected community about the importance of scientific research and give an overview of upcoming developments in the field. Here, we provide a detailed report of the panel discussion (including its organisation, execution, and lessons learned to incorporate into future events) and provide strategies that can be used by other scientific societies to hold similar events in their own communities.

Viruses ◽  
2020 ◽  
Vol 12 (8) ◽  
pp. 815 ◽  
Author(s):  
Chun-Jen Liu ◽  
Pei-Jer Chen

Hepatitis B virus (HBV) infection and its related liver diseases are important health problems worldwide, particularly in the Asia-Pacific region. For the past 4–5 decades, Taiwan’s government and scientists have cooperated together to control this virus infection and its related liver diseases. These efforts and achievements have made progress toward the elimination of HBV. Taiwan’s government initiated the Viral Hepatitis Control Program (VHCP) in the1970s, and then launched the national vaccination program in 1984. This universal vaccination program effectively decreased the rate of hepatitis B carriage and the development of hepatocellular carcinoma (HCC) in the younger generation. Since 2003, approved anti-HBV treatments were reimbursed nationwide. This reimbursement program resulted in a higher uptake of anti-HBV treatments, which contributed to a decrease in liver-related disease progression and subsequently reduced attributable mortality in Taiwan. This experience can be shared by countries in other parts of the world regarding the control of chronic viral hepatitis B.


2002 ◽  
Vol 123 (6) ◽  
pp. 2154-2155
Author(s):  
Satheesh Nair

2016 ◽  
Vol 54 (12) ◽  
pp. 1343-1404
Author(s):  
B Binder ◽  
A Schuch ◽  
B van Wilgenburg ◽  
A Hoh ◽  
P Klenerman ◽  
...  

2020 ◽  
Vol 18 (7) ◽  
Author(s):  
Tatiana Ghelimici ◽  
Iulianna Lupasco ◽  
Vlada-Tatiana Dumbrava ◽  
Inna Vengher ◽  
Natalia Taran ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document